|
|
超声引导下热消融术治疗原发性甲状旁腺功能亢进的研究进展* |
孟欣1,2, 孙立涛1,2** |
1.锦州医科大学,辽宁 锦州 121001;
2.浙江省人民医院超声科,浙江 杭州 310014 |
|
[1] MAKRAS P,ANASTASILAKIS A D. Bone disease in primary hyperparathyroidism[J].Metabolism,2018,80: 57-65.
[2] BILEZIKIAN J P, BANDEIRA L, KHAN A,et al. Hyperparathyroidism[J].Lancet,2018,391(10116):168-178.
[3] GUILMETTE J, SADOW P M. Parathyroid pathology[J].Surg Pathol Clin,2019,12(4):1007-1019.
[4] WILHELM S M, WANG T S, RUAN D T, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism[J].JAMA Surg,2016,151(10):959-968.
[5] BILEZIKIAN J P. Primary hyperparathyroidism[J].J Clin Endocrinol Metab,2018,103(11):3993-4004.
[6] CHEN J, CAO J, QIU F, et al. The Efficacy and The safety of ultrasound-guided ablation therapy for treating papillary thyroid microcarcinoma[J].J Cancer,2019,10(21):5272-5282.
[7] HA E J, BAEK J H, BAEK S M. Minimally invasive treatment for benign parathyroid lesions: Treatment efficacy and safety based on nodule characteristics[J].Korean J Radiol,2020,21(12):1383-1392.
[8] PAPINI E, MONPEYSSEN H, FRASOLDATI A,et al. 2020 European Thyroid Association Clinical Practice Guideline for the use of image-guided ablation in benign thyroid nodules[J].Eur Thyroid J,2020,9(4):172-185.
[9] BAEK J H, LEE J H, VALCAVI R,et al. Thermal ablation for benign thyroid nodules: radiofrequency and laser[J].Korean J Radiol,2011,12(5):525-540.
[10] DUC N M, KESERCI B. Emerging clinical applications of high-intensity focused ultrasound[J].Diagn Interv Radiol,2019,25(5):398-409.
[11] SANDHU A, NGUYEN D T. Forging ahead: Update on radiofrequency ablation technology and techniques[J].J Cardiovasc Electrophysiol,2020,31(1):360-369.
[12] HUSSAIN I, AHMAD S, ALJAMMAL J. Radiofrequency ablation of parathyroid adenoma: A novel treatment option for primary hyperparathyroidism[J].AACE Clin Case Rep,2021,7(3):195-199.
[13] SORMAZ I C, POYANLI A, AÇAR S,et al. The results of ultrasonography-guided percutaneous radiofrequency ablation in hyperparathyroid patients in whom surgery is not feasible [J].Cardiovasc Intervent Radiol,2017,40(4):596-602.
[14] FAN B Q, HE X W, CHEN H H, et al.US-guided microwave ablation for primary hyperparathyroidism: A safety and efficacy study[J].Eur Radiol,2019,29(10):5607-5616.
[15] LIU C, WU B, HUANG P, et al. US-Guided percutaneous microwave ablation for primary hyperparathyroidism with parathyroid nodules: feasibility and safety study[J].J Vasc Interv Radiol,2016,27(6):867-875.
[16] BENNEDBAEK F N, KARSTRUP S, HEGEDÜS L. Ultrasound guided laser ablation of a parathyroid adenoma[J].Br J Radiol,2001,74(886):905-907.
[17] JIANG T A, CHEN F, ZHOU X, et al. Percutaneous ultrasound-guided laser ablation with contrast-enhanced ultrasonography for hyperfunctioning parathyroid adenoma: A preliminary case series[J].Int J Endocrinol,2015,2015:673604.
[18] KOVATCHEVA R D, VLAHOV J D, SHINKOV A D, et al. High-intensity focused ultrasound to treat primary hyperparathyroidism: A feasibility study in four patients[J].AJR Am J Roentgenol,2010,195(4):830-835.
[19] KOVATCHEVA R, VLAHOV J, STOINOV J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism[J].Eur Radiol,2014,24(9):2052-2058.
[20] BEER E. Removal of neoplasms of the urinary bladder: A new method, employing high-frequency (oudin) currents through a catheterizing cystoscope[J].Am J Med,1952,13(5):542-543.
[21] NI W J, YUAN Y, CHU X Q, et al. Bone turnover markers in response to ultrasound-guided microwave ablation for primary hyperparathyroidism[J].Front Endocrinol (Lausanne),2021,12:782050.
[22] ANDRIOLI M, RIGANTI F, PACELLA C M, et al. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: Present and future perspectives[J].AJR Am J Roentgenol,2012,199(5):1164-1168.
[23] LIU F Y, YU X L, Liu Z L, et al. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism[J].Int J Hyperthermia,2019,36(1):835-840.
[24] DUC N M, KESERCI B. Emerging clinical applications of high-intensity focused ultrasound[J].Diagn Interv Radiol,2019,25(5):398-409. |
[1] |
由春梅, 陆艺丹, 张锋, 吴艳芳, 方琪. 颈动脉重度狭窄患者血管内治疗术后发生高灌注综合征的研究进展*[J]. 医学临床研究, 2024, 41(3): 321-324. |
[2] |
夏傅文, 李敏, 陈海顺, 刘建昆. 戊型肝炎病毒感染对肝细胞癌发生、发展影响的研究进展[J]. 医学临床研究, 2024, 41(2): 164-167. |
[3] |
殷莉, 曹贤达, 张华妮, 瞿涛, 顾秀峰, 程刚. 民族药文王一支笔的临床应用研究进展[J]. 医学临床研究, 2023, 40(8): 1121-1123. |
[4] |
刘雪纯, 荆雪. 炎症性肠病与常见微量元素缺乏的研究进展[J]. 医学临床研究, 2023, 40(5): 641-643. |
[5] |
刘界, 王国华. SWE技术定量评估椎旁肌在腰椎退行性疾病中的应用进展[J]. 医学临床研究, 2023, 40(5): 644-647. |
[6] |
张宁, 李玉凤, 张景华. 乳腺炎诊断及治疗措施研究进展[J]. 医学临床研究, 2023, 40(4): 596-599. |
[7] |
崔秋利, 赵云清. miRNA-21在急性心肌梗死发生、发展中的作用机制[J]. 医学临床研究, 2023, 40(4): 600-602. |
[8] |
杨娇娇, 季伟伟, 任建民, 肖晓燕. 功能磁共振在糖尿病肾病中的研究进展[J]. 医学临床研究, 2023, 40(3): 435-437. |
[9] |
徐凯, 王守界, 陈晓玲, 施帮辉, 王辉, 谈伟强. 色素减退性瘢痕治疗的相关研究进展[J]. 医学临床研究, 2023, 40(1): 1-3. |
[10] |
侯龙辉, 韦杨超. PD-1单抗联合微波消融治疗原发性肝癌的临床疗效[J]. 医学临床研究, 2023, 40(1): 95-97. |
[11] |
郭自炎, 成建钊. 自体动静脉内瘘扣眼穿刺感染及预防策略的研究进展[J]. 医学临床研究, 2022, 39(9): 1281-1283. |
[12] |
周洁, 刘金沙, 刘展. 乳清蛋白在低蛋白血症患者中的应用现状[J]. 医学临床研究, 2022, 39(7): 1079-1081. |
[13] |
朱罡, 周鹏. 肝癌患者CT 引导下经皮微波消融术治疗前后外周血Th17细胞及相关细胞因子的变化[J]. 医学临床研究, 2022, 39(2): 310-312. |
[14] |
彭娟, 张静. 糖尿病微血管并发症的发病机制及药物治疗的研究进展[J]. 医学临床研究, 2022, 39(1): 104-107. |
[15] |
余无际, 王国华. 颈腰椎间盘退变及脊柱融合固定术对脊柱生物力学影响的有限元分析研究进展[J]. 医学临床研究, 2021, 38(7): 961-965. |
|
|
|
|